Skip to main content
Year archive

STARSOURCE MULTITRADE LIMITED — 2023 filings

All 46 regulatory filings released by STARSOURCE MULTITRADE LIMITED (506365) in 2023, sourced directly from the official regulator.

46 Filings
2023 Period
2023 filings (46)
Filing Released Lang
Intimation of Trading Window Closure
Regulatory Filings
2023-12-29 English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulation, 2015
Share Issue/Capital Change
2023-12-12 English
Submission of Newspaper Advertisement of Unaudited Financial Services for the Quarter and Half Year Ended September 30 2023
Regulatory Filings
2023-10-30 English
Approval of Un-Audited Financial Results for the Quarter and Half Year Ended September 30, 2023 along with the Limited Review Report thereon.
Regulatory Filings
2023-10-27 English
Approval of Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2023 along with the Limited Review Report thereon.
Regulatory Filings
2023-10-27 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 ,inter alia, to consider and approve the Un-Audited ....
Regulatory Filings
2023-10-16 English
Declaration of Non-Applicability of Regulation 23(9) of SEBI (LODR) Regulation, 2015 for the half year ended September 30, 2023
Regulatory Filings
2023-10-09 English
Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 for the Quarter Ended September 30, 2023.
Regulatory Filings
2023-10-04 English
Intimation of Trading Window Closure
Regulatory Filings
2023-09-29 English
VOTING RESULTS AND CONSOLIDATED SCRUTINIZER''S REPORT OF THE 81ST ANNUAL GENERAL MEETING AS PER REGULATION 44 OF SEBI (LODR) REGULATIONS, 2015
Regulatory Filings
2023-09-26 English
Proceeding/Outcome of the 81st Annual General Meeting as per Regulation 30 Read with Schedule III OF SEBI (LODR) Regulations, 2015
Regulatory Filings
2023-09-25 English
Please find enclosed herewith a copy of Newspaper Advertisement published on September 02, 2023 in Business Standard (English) and Mumbai Lakshawadeep (Marathi) regarding the Notice 81st ....
Regulatory Filings
2023-09-04 English
This is to inform that the 81st Annual General Meeting of the Company is scheduled to be held on Monday, 25th September, 2023 at 04:00 p.m. at the Registered office of the Company at 5-Kumud ....
Regulatory Filings
2023-08-29 English
Submission of Newspaper Advertisement of Unaudited Financial Results for the Quarter Ended June 30, 2023
Earnings Release
2023-07-31 English
Intimation of Book Closure Pursuant to the Regulation 42(2) to 4 of SEBI (LODR) Regulations, 2015
Regulatory Filings
2023-07-27 English
Approval of Un-Audited Financial Results of the Company for the Quarter Ended June 30, 2023 along with the Limited Review Report thereon.
Regulatory Filings
2023-07-27 English
1. Approval of Un-Audited Financial Results of the Company for the quarter ended June 30, 2023 along with the Limited Review Report thereon. 2. Approval of the Notice of the ....
Regulatory Filings
2023-07-27 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 ,inter alia, to consider and approve 1. the Un-Audited ....
Regulatory Filings
2023-07-14 English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulation, 2015
Regulatory Filings
2023-07-14 English
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the Quarter Ended June 30, 2023
Regulatory Filings
2023-07-04 English
Intimation of Trading Window Closure
Regulatory Filings
2023-06-30 English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015
Regulatory Filings
2023-06-26 English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015
Regulatory Filings
2023-06-13 English
Compliance of Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2023-06-12 English
Mr. Ashok Somani as ceased to Compliance Officer of the Company.
Regulatory Filings
2023-06-06 English
Newspaper publication of financial results for the quarter and financial year ended March 31, 2023
Regulatory Filings
2023-05-29 English
Declaration of Non-applicability of Regulation 23(9) of SEBI (LODR) Regulation, 2015
Regulatory Filings
2023-05-29 English
Appointment of M/s. Sarda Soni Associates LLP as an Internal Auditor for the Financial Year 2023-2024
Regulatory Filings
2023-05-24 English
In accordance with the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith is the ....
Regulatory Filings
2023-05-24 English
Audited Financial Results of the Company for the quarter and Financial Year ended March 31, 2023
Regulatory Filings
2023-05-24 English
Outcome of the Board Meeting held on May 24, 2023
Regulatory Filings
2023-05-24 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve 1. To consider ....
Regulatory Filings
2023-05-15 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2023-04-29 English
Non-Applicability of Annual Secretarial Compliance Report for the year ended March 31, 2023 under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015
Regulatory Filings
2023-04-17 English
We hereby submit Compliance Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2023
Regulatory Filings
2023-04-17 English
Please find enclosed compliance certificate for the financial year ended 31st March, 2023 pursuant to Regulation 7(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, ....
Regulatory Filings
2023-04-13 English
Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate for the quarter ....
Regulatory Filings
2023-04-10 English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015
Share Issue/Capital Change
2023-03-31 English
Intimation of Trading Window Closure
Regulatory Filings
2023-03-29 English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015
Regulatory Filings
2023-03-24 English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015
Regulatory Filings
2023-02-28 English
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of the newspaper ....
Regulatory Filings
2023-02-01 English
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the ....
Regulatory Filings
2023-01-31 English
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the ....
Regulatory Filings
2023-01-31 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 ,inter alia, to consider and approve Pursuant to Regulation ....
Board/Management Information
2023-01-05 English
Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate for the quarter ....
Regulatory Filings
2023-01-03 English